Skip to main content

Table 1 Clinical data of patients with OSCC

From: An evaluation of SOX2 and hTERC gene amplifications as screening markers in oral and oropharyngeal squamous cell carcinomas

  # (%) Median age at diagnosis (range) Observation time (range)
Women 17 (0.24) 57 (48–76) years 16 (3–27) months
Men 54 (0.76) 58 (36–84) years 14 (3–24) months
Deceased 10 (0.14)      
Current status unknown 14 (0.2)      
Tumour location # (%)      
Hypopharinx 5 (0.07)      
Larynx 2 (0.03)      
Lips 1 (0.01)      
Mouth: 36 (0.51)      
 Tongue 14 (0.20)      
 Floor of the mouth 13 (0.18)      
 Retromolar trigone 3 (0.04)      
 Lower alveolus 3 (0.04)      
 Buccal mucosa 2 (0.03)      
 Upper alveolus 1 (0.01)      
Oropharynx 27 (0.38)      
TNM classification       
Tumour # (%) Lymph node status # (%) Distant metastasis # (%)  
Tis 1 (0.01) N0 27 (0.38) M0 69 (0.97)  
T1 5 (0.07) N1 or higher 44 (0.62) M1 2 (0.03)  
T2 20 (0.28)      
T3 11 (0.25)      
T4 34 (0.48)      
Disease stage # (%)   Histologic grading   # (%)  
0 1 (0.01)   Carcinoma in situ   2 (0.03)  
I 4 (0.06)   Grade 1   12 (0.17)  
II 11 (0.15)   Grade 2   45 (0.63)  
III 7 (0.10)   Grade 3   12 (0.17)  
IVA 35 (0.49)      
IVB 11 (0.15)      
IVC 2 (0.03)